GP
STJ

GLG Partners’s St Jude Medical STJ Stock Holding History

GLG Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-363,561
Closed -$29.2M – 574
2016
Q4 		$29.2M Sell
363,561
-64,897
-15% -$5.15M 1.16% 8
2016
Q3 		$34.2M Buy
428,458
+19,081
+5% +$1.54M 1.05% 13
2016
Q2 		$31.9M Buy
+409,377
New +$29.2M 0.96% 16

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

GLG Partners's STJ Position: Q1 2017 in Review

GLG Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 363,561 shares — an estimated $29.2M sold.

GLG Partners first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $34.2M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • GLG Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • GLG Partners sold 363,561 St Jude Medical shares in Q1 2017, an estimated $29.2M.
  • GLG Partners first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • GLG Partners's St Jude Medical position peaked at $34.2M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on GLG Partners's 13F filing for Q1 2017, filed 15 May 2017.